408 related articles for article (PubMed ID: 8989915)
41. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
Wang Y; Zhang Z; Lubet R; You M
Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
[TBL] [Abstract][Full Text] [Related]
42. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
43. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
[TBL] [Abstract][Full Text] [Related]
45. Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains.
Ozaki M; Ozaki K; Watanabe T; Uwagawa S; Okuno Y; Shirai T
Toxicol Pathol; 2005; 33(2):267-71. PubMed ID: 15902970
[TBL] [Abstract][Full Text] [Related]
46. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
[TBL] [Abstract][Full Text] [Related]
47. c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.
Li ZH; Zheng J; Weiss LM; Shibata D
Am J Pathol; 1994 Feb; 144(2):303-9. PubMed ID: 8311114
[TBL] [Abstract][Full Text] [Related]
48. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors.
Mitsumori K; Wakana S; Yamamoto S; Kodama Y; Yasuhara K; Nomura T; Hayashi Y; Maronpot RR
Mol Carcinog; 1997 Nov; 20(3):298-307. PubMed ID: 9397190
[TBL] [Abstract][Full Text] [Related]
49. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions.
Sozzi G; Miozzo M; Pastorino U; Pilotti S; Donghi R; Giarola M; De Gregorio L; Manenti G; Radice P; Minoletti F
Cancer Res; 1995 Jan; 55(1):135-40. PubMed ID: 7805023
[TBL] [Abstract][Full Text] [Related]
50. Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung.
Prahalad AK; Ross JA; Nelson GB; Roop BC; King LC; Nesnow S; Mass MJ
Carcinogenesis; 1997 Oct; 18(10):1955-63. PubMed ID: 9364006
[TBL] [Abstract][Full Text] [Related]
51. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas.
Nuzum EO; Malkinson AM; Beer DG
Mol Carcinog; 1990; 3(5):287-95. PubMed ID: 2244961
[TBL] [Abstract][Full Text] [Related]
52. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ
Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876
[TBL] [Abstract][Full Text] [Related]
53. Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months.
Sills RC; Hong HL; Greenwell A; Herbert RA; Boorman GA; Devereux TR
Carcinogenesis; 1995 Jul; 16(7):1623-8. PubMed ID: 7614698
[TBL] [Abstract][Full Text] [Related]
54. Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene.
Mori I; Yasuhara K; Hayashi SM; Nonoyama T; Nomura T; Mitsumori K
Cancer Lett; 2000 May; 153(1-2):199-209. PubMed ID: 10779650
[TBL] [Abstract][Full Text] [Related]
55. Aberrant expression of cyclin D1 in pulmonary proliferative lesions induced by high doses of urethane in transgenic mice carrying the human prototype c-H-ras gene.
Mori I; Yasuhara K; Hayashi SM; Nonoyama T; Nomura T; Yanai T; Masegi T; Mitsumori K
J Vet Med Sci; 2001 Mar; 63(3):261-8. PubMed ID: 11307925
[TBL] [Abstract][Full Text] [Related]
56. Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.
Kawano R; Takeshima Y; Inai K
Jpn J Cancer Res; 1996 Jan; 87(1):44-50. PubMed ID: 8609047
[TBL] [Abstract][Full Text] [Related]
57. Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice.
Nesnow S; Ross JA; Stoner GD; Mass MJ
Toxicology; 1995 Dec; 105(2-3):403-13. PubMed ID: 8571376
[TBL] [Abstract][Full Text] [Related]
58. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
59. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
60. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions.
Suzui M; Yoshimi N; Tanaka T; Mori H
Mol Carcinog; 1995 Dec; 14(4):294-8. PubMed ID: 8519419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
